Skip to main content
Clinical Trials/JPRN-jRCTs072200027
JPRN-jRCTs072200027Recruiting未知

Instantaneous Wave-free Ratio and Fractional Flow Reserve Pullback Gradient to Guide Revascularization in Patients with Diffuse/tandem Coronary Lesions

Matsuo Hitoshi0 sites300 target enrollmentStarted: August 24, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
300

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • 1.>20 years of age
  • 2.Willing to participate and able to understand, read, and sign the informed consent document before the planned procedure
  • 3.Eligible for coronary angiography and/or percutaneous coronary intervention
  • 4.Patient with at least 2 separate (>10mm apart) or diffuse (>20mm) de novo angiographically 50-90% stenoses in one native major epicardial vessel or their major branches (The stenosis will be regarded as single when the gap is 10mm or shorter between the 2 narrowings)
  • 5.Single coronary artery disease
  • 6.Stable coronary artery disease (with or without a history of PCI)

Exclusion Criteria

  • 1.Previous CABG with patent grafts to the interrogated vessel
  • 2.Total coronary occlusions
  • 3.Cardiogenic shock, or intra-aortic balloon pumping
  • 4.Contraindications to PCI or drug-eluting stent (DES) implantation
  • 5.Malignant disease with unfavorable prognosis that may influence survival within the next 3 years
  • 6.EF < 30%
  • 7.eGFR < 15mL/min/1.73m2
  • 8.Pregnant or planning to be pregnant
  • 9.Frequent arrhythmia
  • 10.Acute coronary syndrome or a history of myocardial infarction
  • 11.Severe valvular heart disease
  • 12.Distal coronary disease < 2.5 mm by visual estimation
  • 13.Baseline flow < TIMI 3 or intracoronary thrombus
  • 14.Included in other intervention trials
  • 15.Weight > 200kg
  • 16.Severe allergy to contrast media
  • 17.Contraindications to antithrombotic therapy

Investigators

Sponsor
Matsuo Hitoshi

Similar Trials